Cancer Radiosensitization Nanoagent to Activate cGAS‐STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy
Advanced Healthcare Materials · 2024-06 · 13 (14)
DOI: 10.1002/adhm.202303626 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024-03. Verfasst von Zede Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Immunotherapy, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Pearl River Talented Young Scholar Program, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Immunotherapy has emerged as an innovative strategy with the potential to improve outcomes in cancer patients. Recent evidence indicates that radiation‐induced DNA damage can activate the cyclic‐GMP‐AMP synthase (cGAS)‐stimulator of interferon genes (STING) pathway to enhance the antitumor immune response. Even so, only a small fraction of patients currently benefits from radioimmunotherapy due to the radioresistance and the inadequate activation of the cGAS‐STING pathway. Herein, this work integrates hafnium oxide (HfO 2 ) nanoparticles (radiosensitizer) and 7‐Ethyl‐10‐hydroxycamptothecin (SN38, chemotherapy drug, STING agonist) into a polydopamine (PDA)‐coated core‐shell nanoplatform (HfO 2 @PDA/Fe/SN38) to achieve synergistic chemoradiotherapy and immunotherapy. The co‐delivery of HfO 2 /SN38 greatly enhances radiotherapy efficacy by effectively activating the cGAS‐STING pathway, which then triggers dendritic cells maturation and CD8 + T cells recruitment. Consequently, the growth of both primary and abscopal tumors in tumor‐bearing mice is efficiently inhibited. Moreover, the HfO 2 @PDA/Fe/SN38 complexes exhibit favorable magnetic resonance imaging (MRI)/photoacoustic (PA) bimodal molecular imaging properties. In summary, these developed multifunctional complexes have the potential to intensify immune activation to realize simultaneous cancer Radio/Chemo/Immunotherapy for clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Imaging Center, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
- Guangzhou Key Laboratory of Tumor Immunology Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
- Guangdong Provincial Key Laboratory of Medical Image Processing, School of Biomedical Engineering, Southern Medical University, Guangzhou, 510515, P. R. China.
- Experimental Education/Administration Center, School of Basic Medical Science, Southern Medical University, Guangzhou, 510515, China.
ORCID-Profile: Yikai Xu
Förderung
- National Natural Science Foundation of China
- Pearl River Talented Young Scholar Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Wu, Z., Li, Q., Zhu, K., Zheng, S., Hu, H., Hou, M., Qi, L., Chen, S., Xu, Y., Zhao, B., & Yan, C. (2024). Cancer Radiosensitization Nanoagent to Activate cGAS‐STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy. Advanced Healthcare Materials, 13(14). https://doi.org/10.1002/adhm.202303626
Vancouver
Wu Z, Li Q, Zhu K, Zheng S, Hu H, Hou M, et al. Cancer Radiosensitization Nanoagent to Activate cGAS‐STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy. Advanced Healthcare Materials. 2024;13(14). doi:10.1002/adhm.202303626
BibTeX
@article{Wu2024,
author = {Wu, Zede and Li, Qiuyu and Zhu, Kai and Zheng, Shuting and Hu, Honglei and Hou, Meirong and Qi, Li and Chen, Siwen and Xu, Yikai and Zhao, Bingxia and Yan, Chenggong},
title = {Cancer Radiosensitization Nanoagent to Activate cGAS‐STING Pathway for Molecular Imaging Guided Synergistic Radio/Chemo/Immunotherapy},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {14},
doi = {10.1002/adhm.202303626}
}
EUVIMED